117th Congress · HOUSE BILLBILL

H.R. 4813Matt’s Act

To limit the price of insulin drugs accessible for participants, beneficiaries, and enrollees enrolled in group or individual health insurance coverage and group health plans and for uninsured individuals who have diabetes, and for other purposes.

Health
Introduced Jul 29, 2021
Last action Jul 30, 2021
Pipeline · Bill → Law
Step 1
Introduced
Jul 29, 2021
Step 2
Referred
Jul 30, 2021
Education and Workforce · E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 4 actions
Jul 30, 2021
Referred to the Subcommittee on Health.
Jul 29, 2021
Introduced in House
Jul 29, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 29, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.